VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $67,207,000 | +20.9% | 4,221,500 | +57.8% | 3.73% | -14.2% |
| Q4 2017 | $55,592,000 | +187.6% | 2,675,259 | +98.3% | 4.35% | +122.0% |
| Q3 2017 | $19,332,000 | -31.1% | 1,349,059 | -16.9% | 1.96% | -23.1% |
| Q2 2017 | $28,073,000 | +9.9% | 1,622,688 | -29.9% | 2.55% | +11.5% |
| Q1 2017 | $25,544,000 | +76.5% | 2,315,900 | +132.4% | 2.28% | +55.3% |
| Q4 2016 | $14,470,000 | +31.8% | 996,589 | +122.8% | 1.47% | +37.1% |
| Q3 2016 | $10,982,000 | +27.9% | 447,351 | +4.9% | 1.07% | +39.7% |
| Q2 2016 | $8,587,000 | +165.9% | 426,381 | +247.1% | 0.77% | +143.8% |
| Q1 2016 | $3,230,000 | – | 122,831 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |